Methylglyoxal-derived hydroimidazolone-1
Methylglyoxal-derived hydroimidazolone-1 has been studied in 2 papers since 2023: 2 observational studies in people; 1 in the past year. The newest paper, Jan 23, 2026: “Methylglyoxal-derived hydroimidazolone (MG-H1) is a novel marker of insulin resistance in Japanese individuals, disturbing insulin signalling via mTORC2 in cultured myocytes”.
2 papers study it3 findingsUpdated
See all 2 papers on methylglyoxal-derived hydroimidazolone-1
At a glance
The findings reach people, from one lab or study. 2 independent labs in 2 countries.
“Higher intakes of dietary AGEs including CEL, CML and MG-H1 were associated with a higher risk of dementia”
None of its findings points the other way.
- 2 independent labs in 2 countries
- Funders: Japan Society for the Promotion of Science and 2 more
- Humans2
What did studies of methylglyoxal-derived hydroimidazolone-1 find?
2Studies of methylglyoxal-derived hydroimidazolone-1 measured 2 outcomes: Akt phosphorylation and glucose uptake.
Akt phosphorylation
downin mouse cells1
1 study
Akt phosphorylation
downin mouse cells1
Methylglyoxal-derived hydroimidazolone-1 decreases Akt phosphorylation in mouse cells.
“pre-treatment with MG-H1 inhibited insulin-stimulated phosphorylation of Akt”
CellsC2C12 skeletal myocytes
Diabetes, obesity & metabolism
Glucose uptake
downin mouse cells1
1 study
Glucose uptake
downin mouse cells1
Methylglyoxal-derived hydroimidazolone-1 decreases glucose uptake in mouse cells.
“pre-treatment with MG-H1 inhibited insulin-stimulated phosphorylation of Akt and glucose uptake, via the activation of mechanistic target of rapamycin complex 2 (mTORC2).”
CellsC2C12 skeletal myocytes
Diabetes, obesity & metabolism
What is methylglyoxal-derived hydroimidazolone-1 linked with?
1Studies link methylglyoxal-derived hydroimidazolone-1 with dementia.
Dementia
upin humans1HR 1.24
1 study
Dementia
upin humans1HR 1.24
Methylglyoxal-derived hydroimidazolone-1 is associated with dementia in humans (Free from dementia at baseline; multivariable-adjusted analysis) (HR 1.24, 95% CI 1.02–1.52).
“Higher intakes of dietary AGEs including CEL, CML and MG-H1 were associated with a higher risk of dementia”
HumansFree from dementia at baseline; multivariable-adjusted analysisHighest versus lowest tertile of intakeMedian follow-up of 11.9 yearsn = 93,830
Clinical nutrition (Edinburgh, Scotland)